Trump says that the tariff of drugs can eventually reach 250 %

president Donald Trump Tell Cnbc’s “Squawk boxOn Tuesday, these planned definitions on imported drugs to the United States can reach 250 %, which is the highest rate It threatens so far.

He said he would initially impose a “small tariff” on medications, but within a year to a year and a half “the maximum”, this rate will be raised to 150 % and 250 %.

The president has repeatedly threatened, of course, the proposals of the tariff, so there is no guarantee that it will eventually put a pharmaceutical tariff at a rate of 250 %. In early July, Trump was It threatened 200 % definitions On medications.

In April, the Trump administration started with the so -called Article 232 investigation On pharmaceutical products. This is the legal authority that allows the Minister of Commerce to investigate the impact of imports on national security.

The tariffs of definitions is the president’s attempt to motivate pharmaceutical companies to transfer manufacturing operations to the United States at a time when the manufacture of domestic drugs has been dramatically reduced over the past few decades. Over the past six months, you love companies Eli Lily and Johnson and Johnson Fresh announced to us Investments To build good intentions with the president.

“We want to make medicines in our country,” Trump told CNBC.

The planning fees for the drug industry will be dealt with, which warned that definitions could increase costs, deter investments in the United States and disrupt the drug supply chain, which endangers patients. Pharmaceutical makers are already moving on the repercussions of Trump’s policies to pricing drugs, which argue with the threat of all of them and their ability to invest in research and development.

This includes Trump’s executive order in May, which revives a controversial plan, which is the “most preferred nation” policy, which aims to reduce the costs of drugs by linking the prices of some drugs in the United States to low drugs abroad.

On Tuesday, Trump CNBC told it that he “called” the “policy of” the most preferred countries “and that it would have” a tremendous impact on the price of medicine. ” But Trump has not officially implemented any changes from the executive order.

Trump last week Messages sent To 17 of the drug makers they claim to adhere to steps to reduce the prices of drugs in the United States by September 29. This includes approval to provide their full portfolio of current medicines at the lowest price that is provided in other developed countries for each medicaid patient, among other steps.

Some pharmaceutical companies said they are retreating messages.